RxDoctor Payments DataLook up a doctor →

Samantha Irwin, NP

Family · Kansas City, MONPI 1144828716

Payments from drug & device makers

$16,575in general payments, 2019–2025

Across 957 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Biogen$2K
  • Livanova USA, Inc.$2K
  • Pfizer$908
  • Teva Pharmaceuticals USA, Inc.$750
  • EMD Serono, Inc.$686
  • plus $8K from 52 others

What the payments were for

  • Consulting fees$1,0006%
  • Travel & lodging$1,0887%
  • Food & beverage$14,38687%
  • Education$1021%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)216$2,870
Biogen42$1,844
Livanova USA, Inc.11$1,657
Pfizer106$908
Teva Pharmaceuticals USA, Inc.75$750
EMD Serono, Inc.35$686
Lilly USA, LLC33$507
Bristol Myers Squibb43$463
Jazz Pharmaceuticals Inc.25$447
UCB, Inc.28$441
Novartis17$403
Acadia Pharmaceuticals Inc25$388
Eisai Inc.18$372
Biohaven Pharmaceuticals, Inc.14$353
MDD US Operations, LLC20$305
Sunovion Pharmaceuticals Inc.22$289
Amgen13$277
Lundbeck LLC16$267
Amneal Pharmaceuticals LLC21$261
Genentech USA, Inc.14$260
Biohaven Pharmaceutical Holding Company Ltd.25$246
Sumitomo Pharma America, Inc.15$235
Sanofi12$231
Johnson & Johnson12$205
Neurocrine Biosciences, Inc.9$198
Banner Life Sciences, LLC9$196
Kyowa Kirin, Inc.11$180
ANI Pharmaceuticals, Inc.7$142
Corium, LLC7$131
SK Life Science, Inc.6$123
Argenx US, Inc.5$106
Neurelis, Inc.4$80
Mallinckrodt Hospital Products Inc.4$70
Axsome Therapeutics, Inc.4$70
Sanofi-aventis U.S. LLC3$68
Otsuka America Pharmaceutical, Inc.3$63
Scilex Pharmaceuticals Inc.3$52
TG Therapeutics, Inc.2$45
Grifols USA, LLC1$39
Ipsen Biopharmaceuticals, Inc2$35
GE HealthCare1$31
Ultragenyx Pharmaceutical Inc.1$25
Vanda Pharmaceuticals Inc.1$21
GRT US Holding, Inc.2$20
Cycle Pharmaceuticals Inc1$19
Avanir Pharmaceuticals, Inc.1$18
Insightec,inc1$18
Urovant Sciences Inc1$17
Alnylam Pharmaceuticals Inc.1$17
Catalyst Pharmaceuticals, Inc.1$17
Genentech, Inc.1$16
Tanabe Pharma America, Inc.1$15
Bridgebio Pharma, Inc.1$14
Upsher-smith Laboratories LLC1$14
Arbor Pharmaceuticals, Inc.1$13
Boston Scientific1$13
Impel Pharmaceuticals Inc.1$12
Myovant Sciences Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,575 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$41,167
Medicare patients
194
Services billed
2,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate48$91,889
BotoxOnabotulinumtoxina61$77,907
EpidiolexCannabidiol (Cbd)11$74,254
QuliptaAtogepant46$57,649
Dimethyl Fumarate14$34,084
Emgality PenGalcanezumab-Gnlm31$31,445
Ajovy AutoinjectorFremanezumab-Vfrm29$28,537
Aimovig AutoinjectorErenumab-Aooe11$9,579
AdlarityDonepezil Hcl18$8,981
Rivastigmine23$5,287
Levetiracetam120$4,807
RivastigmineRivastigmine Tartrate43$3,746
Memantine Hcl147$2,998
Phenobarbital29$2,598
Verapamil Er PmVerapamil Hcl14$2,589

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox, Qulipta$2,870$135,556107 claims
PfizerNurtec Odt$908$91,88948 claims
Corium, LLCAdlarity$131$8,98118 claims
Upsher-smith Laboratories LLCTopiramate$14$1,00294 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →